Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. Piramal Pharma Limited includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization, Piramal Critical Care (PCC), a Complex Hospital Generics business; and the India Consumer Healthcare business, selling over-the-counter products.
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle, serving customers through a globally integrated network of facilities in North America, Europe, and Asia.
Piramal Critical Care (PCC) is a leading, global player in inhaled anesthetics hospital generics, maintaining a wide presence across the USA, Europe and more than 100 countries worldwide.
Piramal Consumer Products Division (CPD) is one of the fastest-growing businesses of Piramal Pharma Limited. It is among the leading players in the Indian self-care space, with established brands like Littles, Lacto Calamine, i-pill, Tetmosol. Polycrol and Tri-Activ, among others, in the Indian Consumer Healthcare market.
AbbVie Therapeutics India Private Limited
AbbVie Therapeutics India Private Limited (formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and Piramal Pharma Limited, commenced commercial operations in 1996 and has emerged as the market leader in the fast-growing ophthalmic category with the successful launches of a series of high technology medication and devices for diseases such as glaucoma, dry eye, infections, and inflammations.